Celcuity (CELC) Cash from Investing Activities (2016 - 2025)

Celcuity (CELC) reported Cash from Investing Activities of $103.4 million for Q4 2025, up 175.32% on a YoY basis from $37.6 million in Q4 2024, and up 140.14% quarter-over-quarter from -$257.6 million in Q3 2025.

Celcuity (CELC) Cash from Investing Activities (2016 - 2025) Analysis & Trends

Celcuity has reported Cash from Investing Activities for 10 years, with the latest figure at $103.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 175.32% year-over-year to $103.4 million; the trailing twelve-month figure through Dec 2025 stood at -$64.1 million (down 1.61% YoY), and the FY2025 full-year result was -$64.1 million, down 1.61% from the prior year.
  • Cash from Investing Activities for Q4 2025 stood at $103.4 million, up from -$257.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $103.4 million in Q4 2025, with the low at -$257.6 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged -$13.8 million across 5 years, with a median of -$10787.0 in 2021.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 1448587.69% — and 2023, when it jumped 188046.29%.
  • Celcuity's Cash from Investing Activities stood at -$9939.0 in 2021, then sank by 1448587.69% to -$144.0 million in 2022, then surged by 71.37% to -$41.2 million in 2023, then jumped by 191.12% to $37.6 million in 2024, then jumped by 175.32% to $103.4 million in 2025.
  • The last three Cash from Investing Activities figures came in at $103.4 million (Q4 2025), -$257.6 million (Q3 2025), and $65.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.89 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 579,519.10
10 Celcuity 4.14 Bn 3.42 Bn - 103.41 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 103.41 Mn
Dec 31, 2025 103.41 Mn
Sep 30, 2025 -257.61 Mn
Sep 30, 2025 -257.61 Mn
Jun 30, 2025 65.86 Mn
Jun 30, 2025 65.86 Mn
Mar 31, 2025 24.26 Mn
Mar 31, 2025 24.26 Mn
Dec 31, 2024 37.56 Mn
Dec 31, 2024 37.56 Mn
Sep 30, 2024 1.90 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 -106.07 Mn
Jun 30, 2024 -106.07 Mn
Mar 31, 2024 3.54 Mn
Mar 31, 2024 3.54 Mn
Dec 31, 2023 -41.22 Mn
Dec 31, 2023 -41.22 Mn
Sep 30, 2023 6.25 Mn
Sep 30, 2023 6.25 Mn